← Back to Search

Behavioral Intervention

Psychotherapy for Suicidal Thoughts in Young People

N/A
Recruiting
Led By Robert J Gregory, MD
Research Sponsored by State University of New York - Upstate Medical University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 6 months
Awards & highlights

Study Summary

This trial assesses whether DDP is more effective than BIC in reducing suicidality among suicidal teens/young adults. Participants receive treatment with safety planning & optional medication mgmt at SUNY Upstate's PHRP for up to 1 year.

Who is the study for?
This trial is for adolescents and young adults aged 14-40 with suicidal thoughts who are fluent in English. They must be willing to be video-recorded, attend outpatient treatment, and have certain scores on suicide ideation scales. It excludes those with schizophrenia, schizoaffective disorder, autism spectrum disorder, low BMI or IQ, or current treatment with DDP or specific medications.Check my eligibility
What is being tested?
The study compares Dynamic Deconstructive Psychotherapy (DDP) against Brief Intervention and Contact (BIC), both supplemented by safety planning and optional medication management. Participants will randomly receive either DDP or BIC at SUNY Upstate Medical University's Psychiatry High Risk Program for up to one year.See study design
What are the potential side effects?
Since this trial involves psychotherapy interventions rather than drugs, typical medical side effects are not expected. However, participants may experience emotional discomfort during therapy sessions as they explore difficult personal issues related to their suicidality.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from Baseline in Suicide Ideation on the Combined Suicide Ideation (CSI) Score at 6 Months of Treatment
Secondary outcome measures
Change from Baseline in Anxiety on the Generalized Anxiety Disorder 7-Item Scale (GAD-7) at 6 Months of Treatment
Change from Baseline in Depression on the Patient Health Questionnaire-9 (PHQ-9) Scale at 6 Months of Treatment
Change from Baseline in Identifying Emotions on the Toronto Alexithymia Scale (TAS20) at 6 Months of Treatment
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Dynamic Deconstructive Psychotherapy (DDP)Experimental Treatment1 Intervention
53 participants will meet with an assigned DDP therapist in-person or through televideo for 50 to 60 minutes on a weekly basis for 12 months. Participants will also meet with a psychiatric provider for a 60-minute psychiatric consultation with at least monthly 30-minute follow-up visits. In addition, participants in this arm will have the option of attending family and group therapy if interested and indicated. At baseline, 3, 6, 9, and 12 months, participants will meet with a research coordinator for 60-minute visits to complete outcome measures.
Group II: Brief Intervention and Contact (BIC)Active Control1 Intervention
53 participants will meet with an assigned BIC therapist in-person or through televideo for an initial 60-minute visit with eight 30-minute follow-up contacts at 1, 2, 4 weeks and 2, 3, 4, 6 and 12 months after study entry. Participants will also meet with a psychiatric provider for a 60-minute psychiatric consultation with at least monthly 30 minute follow-up visits. In addition, participants in this arm will be encouraged to receive services in the community, such as weekly individual psychotherapy, family and group therapy. At baseline, 3, 6, 9, and 12 months, participants will meet with a research coordinator for 60-minute visits to complete outcome measures.

Find a Location

Who is running the clinical trial?

State University of New York - Upstate Medical UniversityLead Sponsor
173 Previous Clinical Trials
27,286 Total Patients Enrolled
Robert J Gregory, MDPrincipal InvestigatorState University of New York - Upstate Medical University

Media Library

Brief Intervention and Contact (BIC) (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05988489 — N/A
Suicidal Thoughts Research Study Groups: Dynamic Deconstructive Psychotherapy (DDP), Brief Intervention and Contact (BIC)
Suicidal Thoughts Clinical Trial 2023: Brief Intervention and Contact (BIC) Highlights & Side Effects. Trial Name: NCT05988489 — N/A
Brief Intervention and Contact (BIC) (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05988489 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research initiative seek to include individuals aged 45 and older?

"This medical trial is targeting individuals aged between 14 and 40 years old."

Answered by AI

Are there still opportunities to partake in this medical experiment?

"According to the data published on clinicaltrials.gov, this particular medical study is no longer recruiting participants. Having first been posted in September of 2023 and last edited on August 4th 2023, it appears that there are 113 other trials actively looking for enrollees presently."

Answered by AI

Might I be a viable candidate for participating in this experiment?

"Admittance into this trial necessitates suicidal inclinations and a patient's age falling within the 14 to 40 range. This experiment is set to accept an approximate total of 106 individuals."

Answered by AI
~71 spots leftby Sep 2025